Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1984 May;39(5):345–351. doi: 10.1136/thx.39.5.345

Effect of antihistamines and antiallergic drugs on responses to allergen and histamine provocation tests in asthma.

M J Phillips, S Ollier, C Gould, R J Davies
PMCID: PMC459800  PMID: 6429878

Abstract

The inhibition of immediate allergen or histamine induced airflow obstruction by inhaled ketotifen, clemastine, sodium cromoglycate, and placebo was studied in two groups of asthmatic subjects. Single doses of ketotifen (0.5 mg), clemastine (0.5 mg), sodium cromoglycate (20 mg), or placebo were administered by inhalation 45 minutes before bronchial provocation testing at weekly intervals, double blind and in random order. Inhalation of ketotifen and clemastine, but not sodium cromoglycate, caused an increase in the amount of histamine which had to be administered to cause a 20% fall in FEV1 from control levels (PD20-FEV1) compared with placebo. The PD20-FEV1 for allergen increased significantly after inhalation of clemastine and sodium cromoglycate. Clemastine, primarily an H1 receptor antagonist, inhibited airflow obstruction after inhalation of both histamine and allergen. Its inhibitory effect on allergen induced asthma did not differ significantly from that of sodium cromoglycate. Ketotifen, when inhaled in a single dose of 0.5 mg before bronchial provocation testing, showed potent antihistamine activity, but there was no evidence of any additional "antianaphylactic" activity.

Full text

PDF
345

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chai H., Farr R. S., Froehlich L. A., Mathison D. A., McLean J. A., Rosenthal R. R., Sheffer A. L., Spector S. L., Townley R. G. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol. 1975 Oct;56(4):323–327. doi: 10.1016/0091-6749(75)90107-4. [DOI] [PubMed] [Google Scholar]
  2. Church M. K., Gradidge C. F. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs. Br J Pharmacol. 1980 Aug;69(4):663–667. doi: 10.1111/j.1476-5381.1980.tb07919.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cockcroft D. W., Ruffin R. E., Dolovich J., Hargreave F. E. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy. 1977 Nov;7(6):503–513. doi: 10.1111/j.1365-2222.1977.tb01481.x. [DOI] [PubMed] [Google Scholar]
  4. Craps L., Greenwood C., Radielovic P. Clinical investigation of agents with prophylactic anti-allergic effects in bronchial asthma. Clin Allergy. 1978 Jul;8(4):373–382. doi: 10.1111/j.1365-2222.1978.tb00472.x. [DOI] [PubMed] [Google Scholar]
  5. Curry J. J. THE EFFECT OF ANTIHISTAMINE SUBSTANCES AND OTHER DRUGS ON HISTAMINE BRONCHOCONSTRICTION IN ASTHMATIC SUBJECTS. J Clin Invest. 1946 Nov;25(6):792–799. doi: 10.1172/JCI101765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eiser N. M., Mills J., Snashall P. D., Guz A. The role of histamine receptors in asthma. Clin Sci (Lond) 1981 Apr;60(4):363–370. doi: 10.1042/cs0600363. [DOI] [PubMed] [Google Scholar]
  7. Girard J. P., Cuevas M. Anti-asthmatic properties of a new peroral drug (HC 20-5II). Acta Allergol. 1977 Feb;32(1):27–34. doi: 10.1111/j.1398-9995.1977.tb02701.x. [DOI] [PubMed] [Google Scholar]
  8. Juniper E. F., Frith P. A., Dunnett C., Cockcroft D. W., Hargreave F. E. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax. 1978 Dec;33(6):705–710. doi: 10.1136/thx.33.6.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kang B., Townley R. G., Lee C. K., Miller Kolotkin B. Bronchial reactivity to histamine before and after sodium cromoglycate in bronchial asthma. Br Med J. 1976 Apr 10;1(6014):867–870. doi: 10.1136/bmj.1.6014.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Karlin J. M. The use of antihistamines in asthma. Ann Allergy. 1972 Jun;30(6):342–347. [PubMed] [Google Scholar]
  11. Kerr J. W., Govindaraj M., Patel K. R. Effect of alpha-receptor blocking drugs and disodium cromoglyate on histamine hypersensitivity in bronchial asthma. Br Med J. 1970 Apr 18;2(5702):139–141. doi: 10.1136/bmj.2.5702.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Martin U., Römer D. The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene. Arzneimittelforschung. 1978;28(5):770–782. [PubMed] [Google Scholar]
  13. Mattson K., Poppius H., Nikander-Hurme R. Preventive effect of ketotifen, a new antiallergic agent, on histamine-induced bronchoconstriction in asthmatics. Clin Allergy. 1979 Jul;9(4):411–416. doi: 10.1111/j.1365-2222.1979.tb02500.x. [DOI] [PubMed] [Google Scholar]
  14. Nogrady S. G., Bevan C. Inhaled antihistamines--bronchodilatation and effects on histamine- and methacholine-induced bronchoconstriction. Thorax. 1978 Dec;33(6):700–704. doi: 10.1136/thx.33.6.700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nogrady S. G., Hartley J. P., Handslip P. D., Hurst N. P. Bronchodilatation after inhalation of the antihistamine clemastine. Thorax. 1978 Aug;33(4):479–482. doi: 10.1136/thx.33.4.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Partridge M. R., Saunders K. B. Effect of an inhaled antihistamine (clemastine) as a bronchodilator and as a maintenance treatment in asthma. Thorax. 1979 Dec;34(6):771–776. doi: 10.1136/thx.34.6.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Phillips M. J., Meyrick Thomas R. H., Moodley I., Davies R. J. A comparison of the in vivo effects of ketotifen, clemastine, chlorpheniramine and sodium cromoglycate on histamine and allergen induced weals in human skin. Br J Clin Pharmacol. 1983 Mar;15(3):277–286. doi: 10.1111/j.1365-2125.1983.tb01500.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Popa V. T. Bronchodilating activity of an H1 blocker, chlorpheniramine. J Allergy Clin Immunol. 1977 Jan;59(1):54–63. doi: 10.1016/0091-6749(77)90177-4. [DOI] [PubMed] [Google Scholar]
  19. Rosenthal R. R., Bruce C. A., Lichtenstein L. M., Norman P. S. The role of inhalation challenge. Int Arch Allergy Appl Immunol. 1975;49(1-2):89–94. doi: 10.1159/000231381. [DOI] [PubMed] [Google Scholar]
  20. Stokes T. C., Morley J. Prospects for an oral Intal. Br J Dis Chest. 1981 Jan;75(1):1–14. doi: 10.1016/s0007-0971(81)80002-2. [DOI] [PubMed] [Google Scholar]
  21. Wuethrich B., Radielovic P., Debelic M. The protective effect of a new oral anti-asthma agent (ketotifen, HC 20--511) against experimentally induced bronchospasm (5 different models). Int J Clin Pharmacol Biopharm. 1978 Sep;16(9):424–429. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES